Total and antigen-(fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 147-153

  Matsuwaki, Yoshinori ^a   Uno, Keisuke ^a   Okushi, Tetsushi ^a   Otori, Nobuyoshi ^a   Moriyama, Hiroshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunoglobulin E; Nasal polyps; Rhinosinusitis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; ANTIGEN; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL;

ADULT; ALLERGIC RHINITIS; ALTERNARIA; ANTIGEN SPECIFICITY; ASPERGILLUS; ASTHMA; CEDAR POLLEN; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DERMATOPHAGOIDES; EOSINOPHIL; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; FUNGAL SINUSITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; NOSE MUCOSA; NOSE POLYP; PENICILLIUM; POLLEN; PRIORITY JOURNAL; RAGWEED POLLEN; TISSUE HOMOGENATE; AGED; ANIMAL; ARTICLE; BLOOD; FUNGUS; IMMUNOLOGY; MIDDLE AGED; MITE; RHINITIS; SINUSITIS;

ADULT; AGED; ANIMALS; ANTIGENS; ENTEROTOXINS; EOSINOPHILS; FEMALE; FUNGI; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; MALE; MIDDLE AGED; MITES; NASAL POLYPS; RHINITIS; SINUSITIS;

MLCS; MLOWN;

EID: 84880541305     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350387     Document Type: Conference Paper

References (26)

1. Matsuwaki Y, Ookushi T, Asaka D, Mori E, Nakajima T, Yoshida T, Kojima J, Chiba S, Ootori N, Moriyama H: Chronic rhinosinus-itis: risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery. Int Arch Allergy Immunol 2008; 146(suppl 1):77-81.
2. Nakayama T, Yoshikawa M, Asaka D, Okushi T, Matsuwaki Y, Otori N, Hama T, Moriyama H: Mucosal eosinophilia and recurrence of nasal polyps-new classification of chronic rhinosinusitis. Rhinology 2011; 49:392-396.
3. Stammberger H: Surgical treatment of nasal polyps: past, present, and future. Allergy 1999; 54:7-11.
4. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S: Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-622.
5. Matsuwaki Y, Yanagi K, Nakajima T, Mori-yama H: Allergic fungal sinusitis. Nihon Jibi-inkoka Gakkai Kaiho 2002; 105:1157-1165.
6. Bent JP 3rd, Kuhn FA: Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 1996; 106:1331-1334.
7. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P: Total and specific IgE in nasal polyps is related to local eo-sinophilic inflammation. J Allergy Clin Immunol 2001; 107:607-614.
8. Seiberling KA, Conley DB, Tripathi A, Gram-mer LC, Shuh L, Haines GK 3rd, Schleimer R, Kern RC: Superantigens and chronic rhinosi-nusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115: 1580-1585.
9. Wise SK, Ahn CN, Lathers DM, Mulligan RM, Schlosser RJ: Antigen-specific IgE in sinus mucosa of allergic fungal rhinosinusitis patients. Am J Rhinol 2008; 22:451-456.
10. Ahn CN, Wise SK, Lathers DM, Mulligan RM, Harvey RJ, Schlosser RJ: Local production of antigen-specific IgE in different anatomic subsites of allergic fungal rhinosinusitis patients. Otolaryngol Head Neck Surg 2009; 141:97-103.
11. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Adinoff AD, Bachert C, Borish L, Chinchilli VM, Danzig MR, Ferguson BJ, Fokkens WJ, Jenkins SG, Lund VJ, Mafee MF, Naclerio RM, Pawankar R, Ponikau JU, Schubert MS, Slavin RG, Stewart MG, Togias A, Wald ER, Winther B: Rhi-nosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006; 118:S17-S61.
12. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM: The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27:615-626.
13. Bush RK, Prochnau JJ: Alternaria-induced asthma. J Allergy Clin Immunol 2004; 113: 227-234.
14. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F: Sensitisation to airborne moulds and severity of asthma: cross-sectional study from European Community Respiratory Health Survey. BMJ Clin Res Ed 2002; 325:411-414.
15. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, Sachs MI: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324:359-363.
16. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H: Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005; 175:5439-5447.
17. Matsuwaki Y, Wada K, White TA, Benson LM, Charlesworth MC, Checkel JL, Inoue Y, Hotta K, Ponikau JU, Lawrence CB, Kita H: Recognition of fungal protease activities induces cellular activation and eosinophil-de-rived neurotoxin release in human eosino-phils. J Immunol 2009; 183:6708-6716.
18. Matsuwaki Y, Wada K, Moriyama H, Kita H: Human eosinophil innate response to Alter-naria fungus through protease-activated re-ceptor-2. Int Arch Allergy Immunol 2011; 155(suppl 1):123-128.
19. Matsuwaki Y, Wada K, White T, Moriyama H, Kita H: Alternaria fungus induces the production of GM-CSF, interleukin-6 and inter-leukin-8 and calcium signaling in human airway epithelium through protease-activated receptor 2. Int Arch Allergy Immunol 2012; 158(suppl 1):19-29.
20. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C: Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997; 99:1492-1499.
21. Yanagihara Y, Kajiwara K, Basaki Y, Ikizawa K, Ebisawa M, Ra C, Tachimoto H, Saito H: Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation. Clin Exp Immunol 1998; 111:136-143.
22. Coker HA, Durham SR, Gould HJ: Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 2003; 171:5602-5610.
23. Takhar P, Smurthwaite L, Coker HA, Fear DJ, Banfield GK, Carr VA, Durham SR, Gould HJ: Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol 2005; 174:5024-5032.
24. Milovanovic M, Drozdenko G, Weise C, Ba-bina M, Worm M: Interleukin-17a promotes IgE production in human B cells. J Invest Der-matol 2010; 130:2621-2628.
25. Agache I, Ciobanu C, Agache C, Anghel M: Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med 2010; 104:1131-1137.
26. Saitoh T, Kusunoki T, Yao T, Kawano K, Ko-jima Y, Miyahara K, Onoda J, Yokoi H, Ikeda K: Role of interleukin-17a in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int Arch Allergy Immunol 2010; 151:8-16.